|
Notice of Annual General Meeting/Proxy Form
|
20 June 2023 at 6:40pm
|
|
Update on North American Expansion Strategy
|
31 May 2023 at 9:20am
|
|
Investor Webinar
|
30 May 2023 at 12:55pm
|
|
Cleansing Notice
|
16 May 2023 at 6:10pm
|
|
Application for quotation of securities - NGS
|
16 May 2023 at 6:10pm
|
|
Final Director's Interest Notice - LF
|
15 May 2023 at 7:35pm
|
|
Proposed issue of securities - NGS
|
9 May 2023 at 10:25am
|
|
Cost Reduction & Cap Raise to Fund North American Expansion
|
9 May 2023 at 10:25am
|
|
Trading Halt
|
5 May 2023 at 10:00am
|
|
Quarterly Activities and Cash Flow Report - March 2023
|
28 April 2023 at 5:20pm
|
|
Appendix 4G and Corporate Governance Statement
|
31 March 2023 at 5:10pm
|
|
Annual Report to shareholders
|
31 March 2023 at 5:05pm
|
|
Broker Briefing Biotech & Nutrition Investor Webinar
|
15 March 2023 at 10:15am
|
|
Walmart expansion
|
8 March 2023 at 9:50am
|
|
Investor Webinar
|
6 March 2023 at 10:30am
|
|
Results and Strategy Presentation
|
24 February 2023 at 10:25am
|
|
FY22 Preliminary Results
|
24 February 2023 at 9:15am
|
|
Preliminary Final Report
|
24 February 2023 at 9:10am
|
|
New CEO Appointed to Drive North American Growth
|
23 February 2023 at 9:35am
|
|
Quarterly Activities and Cash Flow Report - December 2022
|
31 January 2023 at 9:45am
|
|
Director Service Agreement
|
31 January 2023 at 9:35am
|
|
Walmart Expands Distribution of NGS Product Lines
|
30 January 2023 at 9:30am
|
|
Notification of cessation of securities - NGS
|
16 January 2023 at 8:20pm
|
|
NGS commences clinical study with sports supplement
|
11 January 2023 at 9:10am
|
|
Change of Director's Interest Notice - DF
|
22 December 2022 at 6:20pm
|
|
Business Update
|
16 December 2022 at 10:15am
|
|
NGS expands into Poland
|
1 December 2022 at 11:40am
|
|
Change of Director's Interest Notice - PO
|
21 November 2022 at 8:20pm
|
|
Change of Director's Interest Notice - DF
|
21 November 2022 at 8:15pm
|
|
Cleansing Notice
|
21 November 2022 at 8:10pm
|
|
Application for quotation of securities - NGS
|
21 November 2022 at 8:00pm
|
|
Results of Meeting
|
17 November 2022 at 8:15pm
|
|
FY22 Q3 Webinar
|
2 November 2022 at 2:10pm
|
|
Application for quotation of securities - NGS
|
1 November 2022 at 10:10am
|
|
Quarterly Activities and Cash Flow Report - September 2022
|
31 October 2022 at 9:30am
|
|
Release of Shares From Escrow
|
21 October 2022 at 8:00pm
|
|
Nutritional Growth Solutions positive clinical trial results
|
18 October 2022 at 10:20am
|
|
Notice of General Meeting/Proxy Form
|
13 October 2022 at 2:10pm
|
|
Change of Director's Interest Notice - DF
|
6 October 2022 at 5:45pm
|
|
Notification regarding unquoted securities - NGS
|
6 October 2022 at 5:40pm
|
|
Trading Update
|
4 October 2022 at 9:40am
|
|
Investor Webinar Presentation
|
30 September 2022 at 9:45am
|
|
Investor Webinar Presentation
|
29 September 2022 at 10:05am
|
|
NGS on shelves in Walmart stores across the US
|
26 September 2022 at 10:05am
|
|
Cleansing Notice
|
31 August 2022 at 10:25am
|
|
Application for quotation of securities - NGS
|
31 August 2022 at 10:15am
|
|
Appendix 4D and Half Year Report
|
31 August 2022 at 9:30am
|
|
Final Director's Interest Notice
|
31 August 2022 at 9:20am
|
|
Initial Director's Interest Notice
|
31 August 2022 at 9:10am
|
|
NGS Appoints Peter Osborne as Non-Executive Director
|
31 August 2022 at 9:00am
|
